Director, President and CEO · Faeth Therapeutics, Inc. · Common Stock
Side
BUY
Value
$55K
Shares
2,806
Price
$19.76
Executed
Jun 22, 2026
Disclosed
Jun 24, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 22 executedJun 24, 2026 disclosed
FTH · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Parikh Anand Kiran filed this Form 4 reporting a open-market purchase of FTH on Jun 22, 2026. It became public on Jun 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Parikh Anand Kirancik:0002111813
Issuer
Faeth Therapeutics, Inc.cik:0001829802
Revision history · 0
No field has changed since this record was first ingested.
